Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability Index

No abstract is available for this paper.

• Publication year

  2015

• Venue

  PharmacoEconomics (Auckland)

• Publication date

  2015-06-12

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s40273-015-0298-3PMID 26068945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rational centre selection for RCTs with a parallel economic evaluation--the next step towards increased generalisability?

  2015cited by this paper
• Mediation analysis of the relationship between institutional research activity and patient survival

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Centre Selection for Clinical Trials and the Generalisability of Results: A Mixed Methods Study

  2013cited by this paper
• Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial)

  2013cited by this paper
• Pay-for-Performance in the United Kingdom: Impact of the Quality and Outcomes Framework—A Systematic Review

  2012cited by this paper
• Methods for covariate adjustment in cost-effectiveness analysis that use cluster randomised trials.

  2012influential reference
• Operational and contextual drivers of hospital costs.

  2011cited by this paper
• How representative are clinical study patients with allergic rhinitis in primary care?

  2011cited by this paper
• Bayesian Hierarchical Models Combining Different Study Types and Adjusting for Covariate Imbalances: A Simulation Study to Assess Model Performance

  2011cited by this paper
• Truly inefficient or providing better quality of care? Analysing the relationship between risk-adjusted hospital costs and patients' health outcomes.

  2011cited by this paper
• Variations and Determinants of Hospital Costs for Acute Stroke in China

  2010cited by this paper
• Patients included in randomised controlled trials do not represent those seen in clinical practice: focus on antimicrobial agents.

  2010cited by this paper
• Examining cost variation across hospital departments--a two-stage multi-level approach using patient-level data.

  2010cited by this paper
• Cost variation in diabetes care delivered in English hospitals

  2010cited by this paper
• From randomized controlled trials to observational studies.

  2009cited by this paper
• The Association between Hospital Ownership and Technical Efficiency in a Managed Care Environment

  2009cited by this paper
• Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials.

  2009cited by this paper
• Technical efficiency, specialization and ownership form: evidences from a pooling of Italian hospitals

  2009cited by this paper
• Patients Enrolled in Large Randomized Clinical Trials of Antiplatelet Treatment for Prevention After Transient Ischemic Attack or Ischemic Stroke Are Not Representative of Patients in Clinical Practice: The Netherlands Stroke Survey

  2009cited by this paper
• The Effect of Preoperative and Hospital Characteristics on Costs for Coronary Artery Bypass Graft

  2009cited by this paper
• Differences Between Clinical Trial Participants and Patients in a Population-Based Registry: the German Rectal Cancer Study vs. the Rostock Cancer Registry

  2009cited by this paper
• Factors affecting health-care costs and hospitalizations among diabetic patients in Thai public hospitals.

  2008cited by this paper
• Better outcomes for patients treated at hospitals that participate in clinical trials.

  2008cited by this paper
• National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.

  2007cited by this paper
• Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another

  2007cited by this paper
• The design of simulation studies in medical statistics

  2006cited by this paper
• Moderators of treatment outcomes: clinical, research, and policy importance.

  2006cited by this paper
• External validity of randomised controlled trials: "to whom do the results of this trial apply?".

  2005cited by this paper
• The causes and effects of socio-demographic exclusions from clinical trials.

  2005cited by this paper
• Need for expertise based randomised controlled trials

  2005cited by this paper
• Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages.

  2004cited by this paper
• Generalisability in economic evaluation studies in healthcare: a review and case studies.

  2004cited by this paper
• Evaluating non-randomised intervention studies.

  2003cited by this paper
• Is Volume Related to Outcome in Health Care? A Systematic Review and Methodologic Critique of the Literature

  2002cited by this paper
• A comparison of total hospital costs for percutaneous coronary intervention patients receiving abciximab versus tirofiban

  2001cited by this paper
• How generalizable are the results of large randomized controlled trials of antiretroviral therapy?

  2000cited by this paper
• A tale of two (or more) cities: geographic transferability of pharmacoeconomic data.

  1997cited by this paper
• Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

  1997cited by this paper
• Why we need observational studies to evaluate the effectiveness of health care

  1996cited by this paper
• An Introduction to the Bootstrap

  1995cited by this paper
• Issues in the Cross-National Assessment of Health Technology

  1992cited by this paper
• Better Bootstrap Confidence Intervals

  1987cited by this paper

• Timing of dialysis in acute kidney injury using routinely collected data and dynamic treatment regimes

  2022cites this paper
• Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial

  2022cites this paper
• Identification of tools used to assess the external validity of randomized controlled trials in reviews: a systematic review of measurement properties

  2022cites this paper
• The concept of justifiable healthcare and how big data can help us to achieve it

  2021cites this paper
• Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial

  2019cites this paper
• Relationship between Internal Customer Satisfaction and the External Customer Orientation in an IT Organisation

  2017cites this paper
• Relationship of readability and suitability of a hearing aid user guide and self-efficacy of hearing aid users : a pilot study

  2016cites this paper
• Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review

  2016cites this paper
• Recruitment, screening, and baseline participant characteristics in the WALK 2.0 study: A randomized controlled trial using web 2.0 applications to promote physical activity

  2015cites this paper